Revenue streams and clinical discretion

Journal of the American Geriatrics Society

Volumn 46, Issue 3, 1998, Pages 331-337

  Morreim, E Haavi ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; COST CONTROL; DOCTOR PATIENT RELATION; HEALTH CARE COST; HEALTH CARE DELIVERY; MANAGED CARE; MEDICAL DECISION MAKING; MEDICAL ETHICS; PRACTICE GUIDELINE; PROFIT;

EID: 0031908563     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01048.x     Document Type: Conference Paper

References (96)

1. Hilzenrath DS. Cutting costs - Or quality? Washington Post Natl Wkly Ed August 28-September 3, 1995.
2. Leape LL. Translating medical science into medical practice: Do we need a national medical standards board? JAMA 1995;273:1534-1537.
3. Woolf SH. Practice guidelines: A new reality in medicine - III. Impact on patient care. Arch Intern Med 1993;153:2646-2655.
4. Power EJ. Identifying health technologies that work. JAMA 1995;274:205.
5. Epstein RS, Sherwood LM. From outcomes research to disease management: A guide for the perplexed. Ann Intern Med 1996;124:832-837.
6. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: A report on principles. Ann Intern Med 1995;122:61-70.
7. Kassirer JP, Angell M. The Journal's policy on cost-effectiveness analyses. N Engl J Med 1994;331:669-670.
8. Evans RG. Manufacturing consensus, marketing truth: Guidelines for economic evaluation. Ann Intern Med 1995;123:59-60.
9. Garber AM. Can technology assessment control health spending? Health Aff 1994;13:115-126.
10. Kessler DA, Rose JL, Temple RJ et al. Therapeutic-class wars - Drug promotion in a competitive marketplace. N Engl J Med 1994;334:1350-1353.
11. King Jr RT. In marketing of drugs, Genentech tests limits of what is acceptable. Wall St J January 10, 1995, pp A-1, A-4.
12. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: Problems and potential. Ann Intern Med 1995;123:941-948.
13. Eddy DM. Three battles to watch in the 1990 s. JAMA 1993;270:520-526.
14. McDonald RK. My practice almost destroyed me. Med Econ 1996;73:181-187.
15. Trauner JB, Chestnutt JS. Medical groups in California: Managing care under capitation. Health Aff 1996;15:159-170.
16. News and Commentary. Limit referrals, HMO demands of physicians. Manag Care 1996;5:8-9.
17. Felsenthal E. When HMOs say no to health coverage, more patients are taking them to court. Wall St J May 17, 1996, pp B-1, B-6.
18. Roulidis AC, Schulman KA. Physician communication in managed care organizations: Opinions of primary care physicians. J Fam Pract 1994;39:446-451.
19. Epstein RM. Communication between primary care physicians and consultants. Arch Fam Med 1995;4:403-409.
20. Azavedo D. Did an HMO doctor's greed kill Joyce Ching? Med Econ 1996;73:43-56.
21. Larson E. The soul of an HMO. Time 1996;147:44-52.
22. 23% liability rate increase request pegged to managed care. Am Med News April 1, 1996, p 29 .
23. Gold MR, Hurley R, Lake T et al. A national survey of the arrangements managed-care plans make with physicians. N Engl J Med 1995;333:1678-1683.
24. Goldfarb S. Physicians in control of the capitated dollar: Do unto others. Ann Intern Med 1995;1:546-547.
25. Shapiro MF, Wenger NS. Rethinking utilization review. N Engl J Med 1995;333:1353-1354.
26. Bree RL, Kazerooni EA, Katz SJ. Effect of mandatory radiology consultation on inpatient imaging use. JAMA 1996;276:1595-1598.
27. Horn SD, Sharkey PD, Tracy DM et al. Intended and unintended consequences of HMO cost-containment strategies: Results from the managed care outcomes project. Am J Manag Care 1996;2:253-264.
28. Soumerai SB, McLaughlin TJ, Ross-Degnan D et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331:650-655.
29. Soumerai SB, Ross-Degnan D, Avorn J et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-1077.
30. Soumerai DS, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: Research in need of discipline. Milbank Q 1993;7:217-252.
31. Schroeder SA, Cantor JC. On squeezing balloons: Cost control fails again. N Engl J Med 1991;325:1099-1100.
32. Gerber PC, Bijlefeld M. Watch out for these malpractice hot spots. Physicians Manag 1996;36:37-50.
33. Kirsner RS, Federman DB. Lack of correlation between internists' ability in dermatology and their patterns of treating patients with skin disease. Arch Dermatol 1996;132:1043-1046.
34. Gerbert M, Baurer T, Berger T et al. Primary care physicians as gatekeepers in managed care: Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. Arch Dermatol 1996;132:1030-1038.
35. Weiner JP, Parente ST, Garnick DW et al. Variation in office-based quality: A claims-based profile of care to Medicare patients with diabetes. JAMA 1995;273:1503-1508.
36. Harris HM. Disease management: New wine in new bottles? Ann Intern Med 1996;124:838-842.
37. Page L. Can plans manage the preventive care diabetics need? Am Med News March 20, 1995, pp 4-5.
38. Blumenthal D. Effects of market reforms on doctors and their patients. Health Aff 1996;15:170-184.
39. Prager LO. Gatekeepers on trial. Am Med News February 12, 1996, pp 1, 71, 72.
40. Miller RH. Health system integration: A means to an end. Health Aff 1996;15:92-106.
41. Barr DA. The effects of organizational structure on primary outcomes under managed care. Ann Intern Med 1995;122:353-359.
42. Wasson JH, Sauvigne AE, Mogielnicki RP et al. Continuity of outpatient care in elderly men: A randomized trial. JAMA 1984;252:2413-2417.
43. Shear CL, Give BT, Mattheis JK, Levy MR. Provider continuity and quality of medical care: A retrospective analysis of prenatal and perinatal outcome. Med Care 1983;21:1204-1210.
44. Kaplan SH, Greenfield S, Gandek B et al. Characteristics of physicians with participatory decision-making styles. Ann Intern Med 1996;124:497-504.
45. Lipkin M. Sisyphus or Pegasus? The physician interviewer in the era of corporatization of care. Ann Intern Med 1996;124:511-513.
46. Ferber JD. Auto-assignment and enrollment in Medicaid managed care programs. J Law Med Ethics 1996;24:99-107.
47. Grandinetti D. Can you trust an HMO with your elderly patients? Med Econ 1997;74:94-109.
48. Johnsson J. Insurer-HMO mega-merger. Am Med News April 22-29, 1996, pp 1, 23.
49. Anders G, Winslow R The HMO trend: Big, bigger, biggest. Wall St J March 30, 1995, pp B-1, B-4.
50. Johnsson J. MedPartners, Carmark merge into $4.4 billion firm. Am Med News 6/3/96, 1, 52.
51. Tokarski C. Huge merger aims for East coast. Am Med News June 17, 1996, pp 1, 38, 39.
52. Robinson JC. The dynamics and limits of corporate growth in health care. Health Aff 1996;15:155-169.
53. Robinson JC, Casalino LP. Vertical integration and organizational networks in health care. Health Aff 1996;15:7-22.
54. Ginsburg PB, Grossman J. Health system change: The view from Wall Street. Health Aff 1995;14:159-163.
55. Dranove D, Durkac A, Shanley M. Are multihospital systems more efficient? Health Aff 1996;15:100-105.
56. Miller R. Competition in the health system: Good news and bad news. Health Aff 1996;15:107-120.
57. Lipson DJ, De Sa JM. Impact of purchasing strategies on local health care systems. Health Aff 1996;15:62-76.
58. Blendon RJ, Brodie M, Benson J. What should be done now that national health system reform is dead? JAMA 1995;273:243-44.
59. Etheredge L Jones SM, Lewin J. What is driving health system change? Health Aff 1996;15:93-104.
60. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmission? N Engl J Med 1996;334:1441-1447.
61. Roy PJ. Don't shut family physicians out of the hospital. Med Econ 1995;72:21-22, 24.
62. Morreim EH. Gaming the system: Dodging the rules, ruling the dodgers. Arch Intern Med 1991;151:443-447.
63. Terry K. Are PODS the way to go? Med Econ 1996;73:91-106.
64. American College of Physicians. Voluntary purchasing pools: A market model for improving access, quality, and cost in health care. Ann Intern Med 1996;124:845-853.
65. Davis K, Collins KS, Schoen C, Morris C. Choice matters: Enrollees' views of their health plans. Health Aff 1995;14:99-112.
66. Ullman R, Hill JW, Scheye EC, Spoeri RK. Satisfaction and choice: A view from the plans. Health Aff 1997;16:209-217.
67. Schauffler HH, Rodriquez T. Exercising purchasing power to preventive care. Health Aff 1996;15:73-85.
68. Robinson JC. Health care purchasing and market changes in California. Health Aff 1995;14:117-130.
69. Luft HS. Modifying managed competition to address cost and quality. Health Aff 1995;15:23-38.
70. Shewry S, Hunt S, Ramey J Bertko J. Risk adjustment: The missing piece of market competition. Health Aff 1996;15:171-181.
71. Report to the Board of Trustees, AMA. Direct contracting with employers: A strategy to increase physician involvement in the current health care market - An update to B of T Report 27 (A-95). Board of Trustees Report 1-95.
72. Murata SK. Here come big changes in your patients' insurance. Med Econ 1996;73:185-190.
73. O'Brien CL. Direct contracting: Potential legal and regulatory barriers. Minn Med 1996;79:21-25.
74. Slomski AJ. Here they come: Price-conscious patients. Med Econ 1996;73:40-46.
75. Wetzell S. Consumer clout. Minn Med 1996;79:15-19.
76. Butler SM, Moffit RE. The FEHBP as a model for a new Medicare program. Health Aff 1995;14:47-61.
77. Fowles JB, Winer JP, Knutson D et al. Taking health status into account when setting capitation rates: A comparison of risk-adjustment methods. JAMA 1996;276:1316-1321.
78. Newhouse JP, Buntin MB, Chapman JD. Risk adjustment and Medicare: Taking a closer look. Health Aff 1997;16:26-43.
79. Berwick DM. Payment by capitation and the quality of care. N Engl J Med 1996;335:1227-1231.
80. Kane RL, Kane RA. Long-term care. JAMA 1995;273:1691-1692.
81. Landefeld CS, Palmer RM, Kresevic DM et al. A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients. N Engl J Med 1995;332:1338-1344.
82. Stuck AE, Aronow HU, Steiner A et al. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995;333:1184-1189.
83. Rich MW, Beckham V, Wittengerg C et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
84. John M. Keeping outpatients from becoming inpatients. Med Econ 1996;73:81-86.
85. Slomski AJ. Letting good care drive out the bad. Med Econ 1995;72:112-130.
86. Borfitz D. Are you ready for the new grading system? Med Econ 1995;72:151-162.
87. Pincus CR. Where health care is headed now. Med Econ 1995;72:33-41.
88. Slomski AJ. Getting doctors to share what they've learned. Med Econ 1996;73:130-140.
89. Azavedo D. Taking back health care: Doctors must work together. Med Econ 1996;73:156-167.
90. Woolhandler S, Himmelstein DU. Extreme risk - The new corporate proposition for physicians. N Engl J Med 1995;333:1706-1708.
91. Karuza J, Calkins E, Feather J et al. Enhancing physician adoption of practice guidelines. Arch Intern Med 1995;155:625-632.
92. Frank RG, McGuire TG, Newhouse JP. Risk contracts in managed mental health care. Health Aff 1995;14:50-64.
93. Overbay A, Hall M. Insurance regulation of providers that bare risk. Am J Law Med 1996;22:361-387.
94. Goodman JC, Musgrave CL. Patient Power. Washington, DC: Cato Institute, 1992.
95. Gramm P. Why we need medical saving accounts. N Engl J Med 1994;330:1752-1753.
96. Morreim EH. Diverse and perverse incentives in managed care: Bringing the patient into alignment. Widener Law Symp J 1995;1:89-139.